Philip Morris International Acquires Inhaled Drug Specialist Otitopic; Growing Pipeline Of “Beyond Nicotine” Inhaled Therapeutic Products
Acquiring Company
Philip Morris International
Acquired Company
OtiTopic
Description
Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. If approved, the treatment can address the significant unmet medical need of the over 83 million people, in the U.S. alone, at intermediate to high risk for myocardial infarction.
Quick answer
Philip Morris International is acquiring OtiTopic, announced August 9, 2021. Philip Morris International is based in Stamford, Connecticut, United States.
- How much did Philip Morris International pay for OtiTopic?
- The deal value was not disclosed.
- What does Philip Morris International do?
- Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine..
- Where are Philip Morris International and OtiTopic based?
- Philip Morris International is based in Stamford, Connecticut, United States.
- Who are the decision-makers at Philip Morris International?
- Fundz holds 1 contact at Philip Morris International. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Government
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Strongbridge Biopharma Plc Announces Court Hearing Date To Approve Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 23, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- Strongbridge Biopharma Plc Announces Shareholder Approval Of Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 8, 2021)
- Elanco Closes Acquisition Of Kindred Biosciences (August 30, 2021)
- Trirx Completes Acquisition Of Elanco Animal Health Facility In Shawnee, Kansas (August 2, 2021)
Who to call at Philip Morris International, and when
When Philip Morris International changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Philip Morris International raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Philip Morris International, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Philip Morris International. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Philip Morris International makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired OtiTopic?
OtiTopic was acquired by Philip Morris International, based in Stamford. The deal was reported on August 9, 2021. Philip Morris International is publicly traded (PM) and operates in Manufacturing.
When did Philip Morris International acquire OtiTopic?
Philip Morris International's acquisition of OtiTopic was reported on August 9, 2021. Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does OtiTopic do?
OtiTopic is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.